Xoma | XOMA - Ordinary Share Capital


Xoma reported $87K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Agenus USD 35.32M 2.51M Dec/2025
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Ardelyx USD 244.35M 1.38M Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Celldex Therapeutics USD 66.57M 20K Mar/2026
Curis USD 12.93M 12.87M Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Emergent BioSolutions USD 100K 0 Jun/2023
Incyte USD 199.95M 1.49M Mar/2026
MacroGenics USD 63.32M 60K Dec/2025
Novartis USD 1.91B 60K Mar/2026
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.7B 13M Mar/2026
Prothena USD 53.83M 3K Dec/2025
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Xoma USD 87K 1000 Jun/2024